← 產業報告目錄
Nanoparticle Contract Manufacturing Market Size, Share & Trends Analysis Report By Type of Nanoparticles (Metal Nanoparticles, Lipid Nanoparticles, Others), By Manufacturing Scale (Commercial, Clinical, Pre-clinical), By Application (Therapeutics, Diagnostics, Vaccines), By End-user (Pharmaceutical Companies, Biotechnology Companies), By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-06頁數 180報告編號 INSIGHTACE-3f8753bbf7
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Nanoparticle Contract Manufacturing Market on a global scale was estimated at USD 2.4 Bn in 2023 and is set to attain USD 4.3 Bn by 2031, with a projected CAGR of 7.8% between 2024 and 2031.
At its core, Nanoparticle Contract Manufacturing pertains to the outsourcing of the production of nanoparticles to specialized companies equipped with the expertise, technology, and facilities to create and manipula. Stakeholders across the healthcare landscape are expandingly turning to these solutions to meet contemporary demands.
Market momentum is bolstered by expanding requirement advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nanoparticle Contract Manufacturing Market Snapshot
Chapter 4. Global Nanoparticle Contract Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type of Nanoparticles Estimates & Trend Analysis
5.1. by Type of Nanoparticles & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type of Nanoparticles:
5.2.1. Metal Nanoparticles
5.2.2. Lipid Nanoparticles
5.2.3. Others
Chapter 6. Market Segmentation 2: by Manufacturing Scale Estimates & Trend Analysis
6.1. by Manufacturing Scale & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Manufacturing Scale:
6.2.1. Commercial
6.2.2. Clinical
6.2.3. Pre-clinical
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
7.2.1. Therapeutics
7.2.2. Diagnostics
7.2.3. Vaccines
Chapter 8. Market Segmentation 4: by End-user Estimates & Trend Analysis
8.1. by End-user & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:
8.2.1. Pharmaceutical Companies
8.2.2. Biotechnology Companies
Chapter 9. Nanoparticle Contract Manufacturing Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.1.2. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.1.3. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.1.4. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.1.5. North America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.2. Europe
9.2.1. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.2.2. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.2.3. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.2.4. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.2.5. Europe Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.3. Asia Pacific
9.3.1. Asia Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.3.2. Asia Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.3.3. Asia-Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.3.4. Asia-Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.3.5. Asia Pacific Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.4. Latin America
9.4.1. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.4.2. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.4.3. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.4.4. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.4.5. Latin America Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
9.5. Middle East & Africa
9.5.1. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Type of Nanoparticles, 2019-2031
9.5.2. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Manufacturing Scale, 2019-2031
9.5.3. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
9.5.4. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2019-2031
9.5.5. Middle East & Africa Nanoparticle Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. AstraZeneca
10.2.2. Evonik Industries AG
10.2.3. Ascendia Pharmaceuticals
10.2.4. Axolabs (LGC Limited)
10.2.5. AVANSA Technology & Services
10.2.6. Ardena Holding NV.
10.2.7. Cytodiagnostics, Inc.
10.2.8. American Elements
10.2.9. Encapsula NanoSciences LLC
10.2.10. Fortis Life Sciences
10.2.11. Hongwu International Group Ltd.
10.2.12. MyBiotech
10.2.13. Nanochemazone
10.2.14. CordenPharma
10.2.15. LSNE Contract Manufacturing
10.2.16. Polymun
10.2.17. TeachNanoIndia
10.2.18. BIOVECTRA
10.2.19. Precision NanoSystems
10.2.20. Emergent BioSolutions
10.2.21. Other Prominent Players
10.2.22. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們